DCF — NORTH OAKS MEDICAL CENTER
Enterprise Value: $186.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$186.2M
Enterprise Value
$47.7M
PV of Cash Flows
$138.5M
PV of Terminal Value
$223.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $288.6M | $25.3M | 9.0% | $8.5M | $7.8M |
| Year 2 | $297.3M | $29.0M | 10.0% | $11.0M | $9.1M |
| Year 3 | $306.2M | $32.9M | 11.0% | $13.7M | $10.3M |
| Year 4 | $315.4M | $35.5M | 11.0% | $15.3M | $10.4M |
| Year 5 | $324.9M | $37.4M | 12.0% | $16.3M | $10.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $186.2M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$280.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08258077335221944
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5